US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

235.27

-0.1500-0.06%

Post-market: 236.531.26+0.54%19:58 EDT

Volume:9.05M

Turnover:2.13B

Market Cap:566.83B

PE:21.33

High:236.00

Open:234.14

Low:232.24

Close:235.42

52wk High:251.71

52wk Low:141.50

Shares:2.41B

Float Shares:2.40B

Volume Ratio:0.98

T/O Rate:0.38%

Dividend:5.14

Dividend Rate:2.18%

EPS(TTM):11.03

EPS(LYR):11.03

ROE:35.03%

ROA:8.68%

PB:6.95

PE(LYR):21.32

Loading ...

Overview Company News Filings

Johnson & Johnson submits EMA application for TECVAYLI monotherapy in relapsed or refractory multiple myeloma

Tecvayli®▼ (Teclistamab) Monotherapy Application Submitted to the Ema for Relapsed/Refractory Multiple Myeloma After at Least One Prior Therapy

THOMSON REUTERS

European Commission approves Johnson & Johnson’s AKEEGA for BRCA1/2-mutated mHSPC

J&J - European Commission Approves Akeega for Brca1/2-Mutated Prostate Cancer

THOMSON REUTERS

Premier Foods appoints Matt Roberts as Chief Customer Officer

Perrigo Co. PLC Stock Underperforms Friday When Compared To Competitors

Market Chatter: Johnson & Johnson Units to Pay $65 Million to Settle Tracleer Antitrust Lawsuit

MT Newswires Live

Procept BioRobotics names Daniel Puckett to board and audit committee

Johnson & Johnson Is Maintained at Neutral by JP Morgan

Contineum Q4 FY2025 net loss totals USD 15.2 million as G&A expenses rise 8.0% to USD 4.4 million

Press Release: Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones

Johnson & Johnson Announces U.S. FDA Approval of Tecvayli® Plus Darzalex Faspro® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line

THOMSON REUTERS

FDA approves Johnson & Johnson’s Tecvayli plus Darzalex Faspro for relapsed or refractory multiple myeloma

Johnson & Johnson's Janssen Biotech Unit Secures US FDA Approval for Multiple Myeloma Treatment

MT Newswires Live

US FDA approves JNJ's blood cancer drug

BRIEF-FDA Grants Third Approval Under National Priority Voucher Program

US FDA - Approves Tec-Dara for Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS

United Therapeutics Seen as Top Pick on Multiple Near-Term Catalysts, UBS Says

MT Newswires Live

Dow's 400-Point Fall Led By Losses In Shares Of Walmart, Merck

Johnson & Johnson price target raised to $250 from $225 at JPMorgan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JNJ/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JNJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"Johnson & Johnson","latestPrice":235.27,"timestamp":1774382400000,"preClose":235.42,"halted":0,"volume":9046201,"hourTrading":{"tag":"盘后","latestPrice":236.53,"preClose":235.27,"latestTime":"19:58 EDT","volume":2207504,"amount":519361164.221,"timestamp":1774396684200,"change":1.26,"changeRate":0.005356,"amplitude":0.012107},"delay":0,"changeRate":-0.0006371591198707726,"floatShares":2404573193,"shares":2409295102,"eps":11.03,"marketStatus":"Closed","change":-0.15,"latestTime":"03-24 16:00:00 EDT","open":234.14,"high":236,"low":232.2365,"amount":2125507599.33135,"amplitude":0.015986,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":11.03,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":235.42,"dividendRate":0.021847,"preHourTrading":{"tag":"盘前","latestPrice":234.26,"preClose":235.42,"latestTime":"09:29 EDT","volume":2944,"amount":690160.1536,"timestamp":1774358965813,"change":-1.16,"changeRate":-0.004927,"amplitude":0.013635},"postHourTrading":{"tag":"盘后","latestPrice":236.53,"preClose":235.27,"latestTime":"19:58 EDT","volume":2207504,"amount":519361164.221,"timestamp":1774396684200,"change":1.26,"changeRate":0.005356,"amplitude":0.012107},"volumeRatio":0.981678,"impliedVol":0.288,"impliedVolPercentile":0.9283},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","floatShares":2404573193,"roa":"8.68%","roe":"35.03%","lyrEps":11.033176,"volumeRatio":0.981678,"shares":2409295102,"dividePrice":5.14,"high":236,"amplitude":0.015986,"preClose":235.42,"low":232.2365,"week52Low":141.5,"pbRate":"6.95","psRate":"6.02","week52High":251.71,"institutionHeld":0.6749,"latestPrice":235.27,"eps":11.03,"divideRate":0.021847,"volume":9046201,"delay":0,"ttmEps":11.03,"open":234.14,"prevYearClose":206.95,"prevWeekClose":235.37,"prevMonthClose":248.43,"prevQuarterClose":206.95,"fiveDayClose":238.11,"twentyDayClose":246.28,"sixtyDayClose":207.78,"earningDate":1776096000000,"earningTime":"盘前","dividendPayoutRate":0.4616488786647534,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.04684317718940927,"fiveYearAvgDividendRate":0.02765517773133667},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JNJ\",params:#limit:5,,,undefined,":[{"date":"2026-04-14","symbol":"JNJ","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":2.69,"defaultRemindTime":1776153600000,"name":null,"time":"Pre-Market","dateTimestamp":1776139200000,"actualEps":null},{"date":"2026-02-24","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-24","defaultRemindTime":1771943400000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-10","payableDate":"2026-02-24","currency":"USD","dateTimestamp":1771909200000,"payDate":"2026-03-10"},{"market":"US","date":"2026-01-21","symbol":"JNJ","fiscalQuarterEnding":"2025/12","expectedEps":2.43,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1768971600000,"reportTimeType":"pre","actualEps":2.04},{"date":"2025-11-25","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-25","defaultRemindTime":1764081000000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-09","payableDate":"2025-11-25","currency":"USD","dateTimestamp":1764046800000,"payDate":"2025-12-09"},{"market":"US","date":"2025-10-14","symbol":"JNJ","fiscalQuarterEnding":"2025/09","expectedEps":2.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1760414400000,"reportTimeType":"pre","actualEps":2.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JNJ\",market:\"US\",,,undefined,":[{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.8,"currency":"USD"},{"executeDate":"2016-08-19","recordDate":"2016-08-23","paymentDate":"2016-09-06","value":0.8,"currency":"USD"},{"executeDate":"2016-11-18","recordDate":"2016-11-22","paymentDate":"2016-12-06","value":0.8,"currency":"USD"},{"executeDate":"2017-02-24","recordDate":"2017-02-28","paymentDate":"2017-03-14","value":0.8,"currency":"USD"},{"executeDate":"2017-05-25","recordDate":"2017-05-30","paymentDate":"2017-06-13","value":0.84,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JNJ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1786,"buy":0.4286,"hold":0.3929,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":28,"updateTime":1773633600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JNJ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JNJ","date":"2026-03-23","current":21.330009,"percent":0.366667,"low":8.579006,"twenty":16.872299,"median":23.410585,"eighty":26.25545,"high":36.412821,"avg":21.646638,"sd":6.743796,"marketCap":566915293356},"quantilePoints":[{"date":"2021-03-26","current":29.510146,"twenty":21.34329,"median":23.767845,"eighty":30.081908,"marketCap":434212294590},{"date":"2021-04-01","current":29.134403,"twenty":21.35594,"median":23.773685,"eighty":30.081908,"marketCap":428683610793},{"date":"2021-04-09","current":28.851701,"twenty":21.4211,"median":23.786177,"eighty":30.12771,"marketCap":424523934412},{"date":"2021-04-16","current":29.028837,"twenty":21.428126,"median":23.790128,"eighty":30.12771,"marketCap":427130313916},{"date":"2021-04-23","current":28.830009,"twenty":21.447349,"median":23.796452,"eighty":30.12771,"marketCap":435765591466},{"date":"2021-04-30","current":28.351474,"twenty":21.475831,"median":23.817885,"eighty":30.12771,"marketCap":428532531568},{"date":"2021-05-07","current":29.356747,"twenty":21.503927,"median":23.841105,"eighty":30.12771,"marketCap":443727226505},{"date":"2021-05-14","current":29.656412,"twenty":21.531317,"median":23.877391,"eighty":30.12771,"marketCap":448256667630},{"date":"2021-05-21","current":29.785338,"twenty":21.561813,"median":23.895323,"eighty":30.12771,"marketCap":450205380672},{"date":"2021-05-28","current":29.487415,"twenty":21.592765,"median":23.937312,"eighty":30.12771,"marketCap":445702273507},{"date":"2021-06-04","current":28.91596,"twenty":21.615414,"median":23.966133,"eighty":30.12771,"marketCap":437064734617},{"date":"2021-06-11","current":28.739994,"twenty":21.638518,"median":24.015189,"eighty":30.12771,"marketCap":434405004654},{"date":"2021-06-18","current":28.220806,"twenty":21.670392,"median":24.039278,"eighty":30.12771,"marketCap":426557484565},{"date":"2021-06-25","current":28.609326,"twenty":21.861141,"median":24.084813,"eighty":30.12771,"marketCap":432429957652},{"date":"2021-07-02","current":29.440374,"twenty":21.936844,"median":24.121091,"eighty":30.12771,"marketCap":444991256586},{"date":"2021-07-09","current":29.574527,"twenty":21.9912,"median":24.15923,"eighty":30.12771,"marketCap":447018971509},{"date":"2021-07-16","current":29.287057,"twenty":22.008978,"median":24.192461,"eighty":30.12771,"marketCap":442673868104},{"date":"2021-07-23","current":25.462436,"twenty":22.072979,"median":24.243827,"eighty":30.12771,"marketCap":452391099355},{"date":"2021-07-30","current":25.514348,"twenty":22.099856,"median":24.305908,"eighty":30.12771,"marketCap":453313416242},{"date":"2021-08-06","current":25.64918,"twenty":22.156186,"median":24.365597,"eighty":30.12771,"marketCap":455708974946},{"date":"2021-08-13","current":26.114424,"twenty":22.208673,"median":24.40122,"eighty":30.12771,"marketCap":463974968715},{"date":"2021-08-20","current":26.587076,"twenty":22.280598,"median":24.437878,"eighty":30.12771,"marketCap":472372586588},{"date":"2021-08-27","current":25.62251,"twenty":22.31426,"median":24.507475,"eighty":30.12771,"marketCap":455235128169},{"date":"2021-09-03","current":25.935142,"twenty":22.403746,"median":24.626763,"eighty":30.12771,"marketCap":460789665383},{"date":"2021-09-10","current":24.739435,"twenty":22.438026,"median":24.721919,"eighty":30.12771,"marketCap":439545534901},{"date":"2021-09-17","current":24.410504,"twenty":22.494978,"median":24.721919,"eighty":30.12771,"marketCap":433701424657},{"date":"2021-09-24","current":24.352719,"twenty":22.531175,"median":24.721919,"eighty":30.12771,"marketCap":432674756641},{"date":"2021-10-01","current":23.776349,"twenty":22.581732,"median":24.721919,"eighty":30.12771,"marketCap":422434401303},{"date":"2021-10-08","current":23.844506,"twenty":22.600481,"median":24.721919,"eighty":30.12771,"marketCap":423645343065},{"date":"2021-10-15","current":23.899328,"twenty":22.647017,"median":24.721919,"eighty":30.12771,"marketCap":424619361439},{"date":"2021-10-22","current":24.104584,"twenty":22.670383,"median":24.721919,"eighty":30.12771,"marketCap":430989968102},{"date":"2021-10-29","current":23.981957,"twenty":22.690905,"median":24.721919,"eighty":30.12771,"marketCap":428797394310},{"date":"2021-11-05","current":24.062938,"twenty":22.73421,"median":24.721919,"eighty":30.12771,"marketCap":430245322643},{"date":"2021-11-12","current":24.295572,"twenty":22.75379,"median":24.721919,"eighty":30.12771,"marketCap":434404825854},{"date":"2021-11-19","current":23.98343,"twenty":22.790525,"median":24.721919,"eighty":30.12771,"marketCap":428823720280},{"date":"2021-11-26","current":23.440125,"twenty":22.801141,"median":24.721919,"eighty":30.12771,"marketCap":419109437464},{"date":"2021-12-03","current":23.466628,"twenty":22.824465,"median":24.721919,"eighty":30.12771,"marketCap":419583304919},{"date":"2021-12-10","current":24.366246,"twenty":22.839493,"median":24.721919,"eighty":30.12771,"marketCap":435668472399},{"date":"2021-12-17","current":24.769675,"twenty":22.851504,"median":24.762774,"eighty":30.12771,"marketCap":442881788094},{"date":"2021-12-23","current":24.77262,"twenty":22.874439,"median":24.76352,"eighty":30.12771,"marketCap":442934440034},{"date":"2021-12-31","current":25.187828,"twenty":22.900154,"median":24.774698,"eighty":30.12771,"marketCap":450358363486},{"date":"2022-01-07","current":25.61187,"twenty":22.921295,"median":24.829881,"eighty":30.081908,"marketCap":457940242757},{"date":"2022-01-14","current":24.712253,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":441855075276},{"date":"2022-01-21","current":24.274959,"twenty":22.965167,"median":24.899153,"eighty":30.081908,"marketCap":434036262279},{"date":"2022-01-28","current":21.661741,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":452253833304},{"date":"2022-02-04","current":21.641566,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":451832617789},{"date":"2022-02-11","current":21.147276,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":441512837670},{"date":"2022-02-18","current":20.57272,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":429517246290},{"date":"2022-02-25","current":20.905188,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":436458514228},{"date":"2022-03-04","current":21.343441,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":445608367417},{"date":"2022-03-11","current":21.32707,"twenty":22.962882,"median":24.899153,"eighty":30.081908,"marketCap":445266562557},{"date":"2022-03-18","current":22.021361,"twenty":22.953432,"median":24.899153,"eighty":30.081908,"marketCap":459761966327},{"date":"2022-03-25","current":22.28334,"twenty":22.906658,"median":24.899153,"eighty":30.081908,"marketCap":465231566475},{"date":"2022-04-01","current":22.443298,"twenty":22.88299,"median":24.899153,"eighty":30.081908,"marketCap":468571178104},{"date":"2022-04-08","current":22.938288,"twenty":22.87009,"median":24.899153,"eighty":30.081908,"marketCap":478905566846},{"date":"2022-04-14","current":22.658675,"twenty":22.850073,"median":24.899153,"eighty":30.081908,"marketCap":473067820534},{"date":"2022-04-22","current":24.073645,"twenty":22.862939,"median":24.899153,"eighty":30.081908,"marketCap":477380389882},{"date":"2022-04-29","current":23.946685,"twenty":22.897881,"median":24.899153,"eighty":30.081908,"marketCap":474862769549},{"date":"2022-05-06","current":23.40395,"twenty":22.935305,"median":24.899153,"eighty":30.081908,"marketCap":464100336171},{"date":"2022-05-13","current":23.467645,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":465363409037},{"date":"2022-05-20","current":23.484896,"twenty":22.975012,"median":24.899153,"eighty":30.081908,"marketCap":465705491271},{"date":"2022-05-27","current":24.030285,"twenty":22.985845,"median":24.899153,"eighty":30.081908,"marketCap":476520552686},{"date":"2022-06-03","current":23.410585,"twenty":23.004816,"median":24.899153,"eighty":30.081908,"marketCap":464231906261},{"date":"2022-06-10","current":22.897044,"twenty":23.050406,"median":24.899153,"eighty":30.081908,"marketCap":454048381280},{"date":"2022-06-17","current":22.487007,"twenty":23.028812,"median":24.899153,"eighty":30.081908,"marketCap":445917349705},{"date":"2022-06-24","current":24.189523,"twenty":23.015811,"median":24.900273,"eighty":30.12771,"marketCap":479678234851},{"date":"2022-07-01","current":23.821949,"twenty":23.040512,"median":24.900273,"eighty":30.12771,"marketCap":472389251854},{"date":"2022-07-08","current":23.657404,"twenty":23.071416,"median":24.900273,"eighty":30.12771,"marketCap":469126313617},{"date":"2022-07-15","current":23.650769,"twenty":23.097851,"median":24.900273,"eighty":30.12771,"marketCap":468994743526},{"date":"2022-07-22","current":24.660616,"twenty":23.102569,"median":24.900273,"eighty":30.12771,"marketCap":452916878504},{"date":"2022-07-29","current":24.983365,"twenty":23.140839,"median":24.928435,"eighty":30.12771,"marketCap":458844475275},{"date":"2022-08-05","current":24.495207,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":449878971833},{"date":"2022-08-12","current":23.663478,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":434603436643},{"date":"2022-08-19","current":24.237528,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":445146448022},{"date":"2022-08-26","current":23.516029,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":431895381351},{"date":"2022-09-02","current":23.297002,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":427872736112},{"date":"2022-09-09","current":23.722171,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":435681400400},{"date":"2022-09-16","current":23.992734,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":440650550402},{"date":"2022-09-23","current":23.866758,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":438336872094},{"date":"2022-09-30","current":23.385758,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":429502827647},{"date":"2022-10-07","current":22.933389,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":421194619179},{"date":"2022-10-14","current":23.543228,"twenty":23.140839,"median":24.938619,"eighty":30.12771,"marketCap":432394925531},{"date":"2022-10-21","current":23.154405,"twenty":23.113317,"median":24.898033,"eighty":30.12771,"marketCap":443568940085},{"date":"2022-10-28","current":23.865676,"twenty":23.113317,"median":24.843788,"eighty":30.12771,"marketCap":457194748356},{"date":"2022-11-04","current":23.40302,"twenty":23.113317,"median":24.803493,"eighty":30.12771,"marketCap":448331648928},{"date":"2022-11-11","current":23.098677,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":442501350484},{"date":"2022-11-18","current":24.04719,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":460672011553},{"date":"2022-11-25","current":24.189125,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":463391074504},{"date":"2022-12-02","current":24.412947,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":467678827620},{"date":"2022-12-09","current":23.98441,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459469349094},{"date":"2022-12-16","current":23.974857,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459286335241},{"date":"2022-12-23","current":24.22188,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":464018550570},{"date":"2022-12-30","current":24.108604,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":461848529176},{"date":"2023-01-06","current":24.59992,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":471260670161},{"date":"2023-01-13","current":23.669149,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":453429891962},{"date":"2023-01-20","current":23.029074,"twenty":23.100329,"median":24.77262,"eighty":30.12771,"marketCap":441167963845},{"date":"2023-01-27","current":24.515611,"twenty":23.09784,"median":24.762774,"eighty":29.79261,"marketCap":439834577205},{"date":"2023-02-03","current":23.98808,"twenty":23.09784,"median":24.725504,"eighty":29.701392,"marketCap":430370146548},{"date":"2023-02-10","current":23.629592,"twenty":23.09784,"median":24.702141,"eighty":29.654503,"marketCap":423938516875},{"date":"2023-02-17","current":23.281951,"twenty":23.096013,"median":24.660616,"eighty":29.589162,"marketCap":417701480138},{"date":"2023-02-24","current":22.640351,"twenty":23.085296,"median":24.603297,"eighty":29.518959,"marketCap":406190534678},{"date":"2023-03-03","current":22.357292,"twenty":23.028549,"median":24.566079,"eighty":29.469644,"marketCap":401112176388},{"date":"2023-03-10","current":22.00746,"twenty":22.983363,"median":24.533047,"eighty":29.415426,"marketCap":394835846397},{"date":"2023-03-17","current":22.198308,"twenty":22.961748,"median":24.507475,"eighty":29.316327,"marketCap":398259841984},{"date":"2023-03-24","current":22.237641,"twenty":22.954123,"median":24.458598,"eighty":29.237465,"marketCap":398965513052},{"date":"2023-03-31","current":22.579982,"twenty":22.928011,"median":24.42796,"eighty":29.164815,"marketCap":405107464940},{"date":"2023-04-06","current":24.125619,"twenty":22.901879,"median":24.415005,"eighty":29.109707,"marketCap":432837724314},{"date":"2023-04-14","current":24.198457,"twenty":22.90067,"median":24.40122,"eighty":29.036089,"marketCap":434144522588},{"date":"2023-04-21","current":33.60045,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":427532123321},{"date":"2023-04-28","current":33.481314,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":426016237324},{"date":"2023-05-05","current":33.113231,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":421332755579},{"date":"2023-05-12","current":35.39488,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":450364456873},{"date":"2023-05-16","current":35.078285,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":446336102206},{"date":"2023-05-25","current":34.442897,"twenty":22.896558,"median":24.388256,"eighty":28.974086,"marketCap":438251418186},{"date":"2023-06-02","current":33.976799,"twenty":22.896316,"median":24.385274,"eighty":28.964288,"marketCap":432320784926},{"date":"2023-06-09","current":35.234384,"twenty":22.896073,"median":24.383122,"eighty":28.950456,"marketCap":448322304854},{"date":"2023-06-15","current":35.520199,"twenty":22.89583,"median":24.380969,"eighty":28.928156,"marketCap":451959013929},{"date":"2023-06-23","current":36.412821,"twenty":22.894676,"median":24.377907,"eighty":28.919594,"marketCap":463316736116},{"date":"2023-06-30","current":36.078638,"twenty":22.893522,"median":24.372178,"eighty":28.915612,"marketCap":459064583967},{"date":"2023-07-06","current":33.252114,"twenty":22.892945,"median":24.371306,"eighty":28.914218,"marketCap":423099894750},{"date":"2023-07-14","current":32.435159,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":412704958450},{"date":"2023-07-21","current":34.389724,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":437574843548},{"date":"2023-07-28","current":34.577457,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":451374121486},{"date":"2023-08-04","current":33.973355,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":443488171520},{"date":"2023-08-11","current":34.277968,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":447464594998},{"date":"2023-08-18","current":34.644301,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":452246699051},{"date":"2023-08-25","current":32.868384,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":429063890273},{"date":"2023-09-01","current":29.823849,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":389320523957},{"date":"2023-09-07","current":29.146873,"twenty":22.885028,"median":24.365597,"eighty":28.849755,"marketCap":380483275547},{"date":"2023-09-15","current":30.203841,"twenty":22.879503,"median":24.364936,"eighty":28.833726,"marketCap":394280941321},{"date":"2023-09-20","current":29.919769,"twenty":22.87674,"median":24.363504,"eighty":28.822576,"marketCap":390572668146},{"date":"2023-09-27","current":29.333179,"twenty":22.87009,"median":24.356583,"eighty":28.783898,"marketCap":382915324837},{"date":"2023-10-06","current":28.986391,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":378388342001},{"date":"2023-10-13","current":28.836976,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":376437886630},{"date":"2023-10-20","current":10.593286,"twenty":22.841783,"median":24.323515,"eighty":28.702887,"marketCap":366781928558},{"date":"2023-10-27","current":10.362392,"twenty":22.819032,"median":24.302934,"eighty":28.672744,"marketCap":358787469506},{"date":"2023-11-03","current":10.445631,"twenty":22.769044,"median":24.290222,"eighty":28.617079,"marketCap":361669539868},{"date":"2023-11-10","current":10.249567,"twenty":22.737382,"median":24.269161,"eighty":28.577268,"marketCap":354881014160},{"date":"2023-11-17","current":10.435898,"twenty":22.670731,"median":24.240678,"eighty":28.494304,"marketCap":361332520862},{"date":"2023-11-24","current":10.602761,"twenty":22.660327,"median":24.231704,"eighty":28.462978,"marketCap":367109989550},{"date":"2023-11-30","current":10.575646,"twenty":22.651742,"median":24.221347,"eighty":28.351474,"marketCap":366171150888},{"date":"2023-12-08","current":10.804387,"twenty":22.618791,"median":24.198457,"eighty":28.181371,"marketCap":374091097548},{"date":"2023-12-15","current":10.906591,"twenty":22.590739,"median":24.188733,"eighty":27.750808,"marketCap":377629797119},{"date":"2023-12-22","current":10.765452,"twenty":22.58102,"median":24.177986,"eighty":27.241581,"marketCap":372743021520},{"date":"2023-12-29","current":10.886428,"twenty":22.573561,"median":24.160465,"eighty":27.136313,"marketCap":376931686319},{"date":"2024-01-05","current":11.16801,"twenty":22.53203,"median":24.157661,"eighty":27.08647,"marketCap":386681164730},{"date":"2024-01-12","current":11.204163,"twenty":22.487074,"median":24.126144,"eighty":26.963348,"marketCap":387932949613},{"date":"2024-01-19","current":11.208335,"twenty":22.443298,"median":24.121091,"eighty":26.726065,"marketCap":388077386330},{"date":"2024-01-26","current":11.093616,"twenty":22.419215,"median":24.117255,"eighty":26.720851,"marketCap":384105376607},{"date":"2024-02-02","current":10.844498,"twenty":22.388887,"median":24.117255,"eighty":26.720851,"marketCap":381216642263},{"date":"2024-02-09","current":10.710277,"twenty":22.359324,"median":24.117255,"eighty":26.720851,"marketCap":376498376168},{"date":"2024-02-16","current":10.814367,"twenty":22.324374,"median":24.117255,"eighty":26.720851,"marketCap":380157439670},{"date":"2024-02-23","current":10.994416,"twenty":22.309859,"median":24.117255,"eighty":26.720851,"marketCap":386486701732},{"date":"2024-03-01","current":11.058142,"twenty":22.274272,"median":24.113418,"eighty":26.715636,"marketCap":388726855254},{"date":"2024-03-08","current":10.886151,"twenty":22.230938,"median":24.108604,"eighty":26.715636,"marketCap":382680849512},{"date":"2024-03-15","current":10.914049,"twenty":22.186179,"median":24.098462,"eighty":26.715636,"marketCap":383661560027},{"date":"2024-03-22","current":10.676861,"twenty":22.155506,"median":24.095837,"eighty":26.715636,"marketCap":375323710660},{"date":"2024-03-28","current":10.82836,"twenty":22.121795,"median":24.073645,"eighty":26.715636,"marketCap":380649331209},{"date":"2024-04-05","current":10.45407,"twenty":22.051165,"median":24.060772,"eighty":26.720851,"marketCap":367491915735},{"date":"2024-04-12","current":10.199745,"twenty":22.008009,"median":24.060772,"eighty":26.720851,"marketCap":358551620604},{"date":"2024-04-19","current":8.65562,"twenty":21.962919,"median":24.049911,"eighty":26.720851,"marketCap":351201782289},{"date":"2024-04-26","current":8.719762,"twenty":21.891108,"median":24.032177,"eighty":26.715636,"marketCap":353804347988},{"date":"2024-05-03","current":9.377517,"twenty":21.784557,"median":24.00846,"eighty":26.715636,"marketCap":360809343115},{"date":"2024-05-10","current":9.373138,"twenty":21.660958,"median":23.990791,"eighty":26.715636,"marketCap":360640875572},{"date":"2024-05-17","current":9.650236,"twenty":21.622619,"median":23.98343,"eighty":26.715636,"marketCap":371302464353},{"date":"2024-05-24","current":9.363756,"twenty":21.575231,"median":23.974857,"eighty":26.715636,"marketCap":360279873695},{"date":"2024-05-31","current":9.087284,"twenty":21.542202,"median":23.962574,"eighty":26.715636,"marketCap":349642351706},{"date":"2024-06-07","current":9.158591,"twenty":21.483343,"median":23.946685,"eighty":26.715636,"marketCap":352385965974},{"date":"2024-06-14","current":9.097918,"twenty":21.446612,"median":23.929686,"eighty":26.720851,"marketCap":350051487167},{"date":"2024-06-21","current":9.24366,"twenty":21.36611,"median":23.912184,"eighty":26.726065,"marketCap":355659049663},{"date":"2024-06-28","current":9.11981,"twenty":21.343437,"median":23.902291,"eighty":26.770681,"marketCap":350893824881},{"date":"2024-07-05","current":9.11293,"twenty":21.329201,"median":23.877595,"eighty":26.770681,"marketCap":350629090171},{"date":"2024-07-12","current":9.363756,"twenty":21.294957,"median":23.864994,"eighty":26.770681,"marketCap":360279873695},{"date":"2024-07-15","current":9.375015,"twenty":21.282675,"median":23.856229,"eighty":26.770681,"marketCap":360713075948},{"date":"2024-08-02","current":10.179086,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":386988491906},{"date":"2024-08-09","current":10.144894,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":385688580326},{"date":"2024-08-16","current":10.073344,"twenty":21.285584,"median":23.875766,"eighty":26.859196,"marketCap":382968394983},{"date":"2024-08-23","current":10.279762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":390816009337},{"date":"2024-08-30","current":10.398801,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":395341627431},{"date":"2024-09-06","current":10.446923,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":397171132618},{"date":"2024-09-13","current":10.424762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396328597334},{"date":"2024-09-20","current":10.436159,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396761901194},{"date":"2024-09-27","current":10.218977,"twenty":21.249331,"median":23.875766,"eighty":26.859196,"marketCap":388505055417},{"date":"2024-10-04","current":10.162623,"twenty":21.244537,"median":23.875766,"eighty":26.859196,"marketCap":386362608553},{"date":"2024-10-11","current":10.163256,"twenty":21.204151,"median":23.875766,"eighty":26.859196,"marketCap":386386680990},{"date":"2024-10-18","current":26.962637,"twenty":21.150041,"median":23.875766,"eighty":26.960825,"marketCap":395919365911},{"date":"2024-10-25","current":26.835716,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":394055651827},{"date":"2024-10-31","current":26.333991,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":386688325532},{"date":"2024-11-08","current":25.697817,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":377346748401},{"date":"2024-11-15","current":24.90096,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":365645700757},{"date":"2024-11-22","current":25.496144,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":374385372146},{"date":"2024-11-29","current":25.415802,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":373205636889},{"date":"2024-12-06","current":24.515649,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":359987786773},{"date":"2024-12-13","current":23.977852,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":352090783425},{"date":"2024-12-20","current":23.541712,"twenty":21.14935,"median":23.870477,"eighty":26.963219,"marketCap":345686506319},{"date":"2024-12-27","current":23.869637,"twenty":21.14935,"median":23.866899,"eighty":26.862222,"marketCap":350501752263},{"date":"2025-01-03","current":23.613856,"twenty":21.14935,"median":23.846327,"eighty":26.797423,"marketCap":346745860427},{"date":"2025-01-10","current":23.326922,"twenty":21.148658,"median":23.835219,"eighty":26.622639,"marketCap":342532520226},{"date":"2025-01-17","current":24.228715,"twenty":21.148658,"median":23.815222,"eighty":26.492194,"marketCap":355774446572},{"date":"2025-01-24","current":25.099803,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":353053832614},{"date":"2025-01-31","current":26.166168,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":368053323729},{"date":"2025-02-07","current":26.275715,"twenty":21.148658,"median":23.815222,"eighty":26.451023,"marketCap":369594202431},{"date":"2025-02-14","current":26.915876,"twenty":21.148658,"median":23.815222,"eighty":26.482684,"marketCap":378598712347},{"date":"2025-02-21","current":27.331738,"twenty":21.148658,"median":23.815222,"eighty":26.556741,"marketCap":384448233538},{"date":"2025-02-28","current":28.02496,"twenty":21.148658,"median":23.815222,"eighty":26.658356,"marketCap":394199081144},{"date":"2025-03-07","current":28.384408,"twenty":21.147967,"median":23.81824,"eighty":26.827657,"marketCap":399255076200},{"date":"2025-03-14","current":27.898297,"twenty":21.147967,"median":23.837873,"eighty":27.012809,"marketCap":392417444792},{"date":"2025-03-21","current":27.929289,"twenty":21.164087,"median":23.864994,"eighty":27.693395,"marketCap":392853376781},{"date":"2025-03-28","current":27.948135,"twenty":21.248131,"median":23.876669,"eighty":27.88488,"marketCap":393118460031},{"date":"2025-04-04","current":27.381051,"twenty":21.248131,"median":23.905254,"eighty":27.898419,"marketCap":385141864048},{"date":"2025-04-11","current":25.474211,"twenty":21.248531,"median":23.905255,"eighty":27.898389,"marketCap":358320258825},{"date":"2025-04-17","current":17.005945,"twenty":21.223208,"median":23.911283,"eighty":27.898389,"marketCap":370899663970},{"date":"2025-04-25","current":17.091836,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"marketCap":372772933115},{"date":"2025-05-02","current":17.039985,"twenty":20.756324,"median":23.911734,"eighty":27.898419,"marketCap":371642078674},{"date":"2025-05-09","current":17.172369,"twenty":19.990901,"median":23.911734,"eighty":27.898419,"marketCap":374529366609},{"date":"2025-05-16","current":16.504935,"twenty":17.262967,"median":23.911734,"eighty":27.898419,"marketCap":359972623271},{"date":"2025-05-23","current":16.835894,"twenty":17.138832,"median":23.911734,"eighty":27.898419,"marketCap":367190843108},{"date":"2025-05-30","current":16.942904,"twenty":17.043515,"median":23.911734,"eighty":27.898419,"marketCap":369524734188},{"date":"2025-06-06","current":16.951729,"twenty":17.017922,"median":23.911734,"eighty":27.898419,"marketCap":369717220051},{"date":"2025-06-13","current":17.282689,"twenty":17.017922,"median":23.911734,"eighty":27.898419,"marketCap":376935439888},{"date":"2025-06-20","current":16.628493,"twenty":17.004683,"median":23.912184,"eighty":27.89845,"marketCap":362667425343},{"date":"2025-06-27","current":16.769702,"twenty":16.906498,"median":23.912184,"eighty":27.89845,"marketCap":365747199140},{"date":"2025-07-03","current":17.210981,"twenty":16.898776,"median":23.912184,"eighty":27.89845,"marketCap":375371492256},{"date":"2025-07-11","current":17.396318,"twenty":16.898776,"median":23.912184,"eighty":27.89845,"marketCap":379413695365},{"date":"2025-07-18","current":17.304701,"twenty":16.872299,"median":23.905255,"eighty":27.89845,"marketCap":392141823011},{"date":"2025-07-25","current":18.020297,"twenty":16.872299,"median":23.873915,"eighty":27.89845,"marketCap":408357939136},{"date":"2025-08-01","current":17.508042,"twenty":16.872299,"median":23.864311,"eighty":27.89845,"marketCap":396749745773},{"date":"2025-08-08","current":18.229662,"twenty":16.872299,"median":23.835219,"eighty":27.89845,"marketCap":413102366714},{"date":"2025-08-15","current":18.568685,"twenty":16.872299,"median":23.814665,"eighty":27.89845,"marketCap":420784967715},{"date":"2025-08-22","current":19.01611,"twenty":16.872299,"median":23.808501,"eighty":27.89845,"marketCap":430924074366},{"date":"2025-08-29","current":18.646267,"twenty":16.872299,"median":23.782296,"eighty":27.89845,"marketCap":422543055092},{"date":"2025-09-05","current":18.998043,"twenty":16.868107,"median":23.745347,"eighty":27.900551,"marketCap":430514656758},{"date":"2025-09-12","current":18.970411,"twenty":16.872299,"median":23.733548,"eighty":27.89845,"marketCap":429888488652},{"date":"2025-09-19","current":18.50917,"twenty":16.872299,"median":23.723009,"eighty":27.89845,"marketCap":419436297947},{"date":"2025-09-26","current":18.888578,"twenty":16.872299,"median":23.712233,"eighty":27.89845,"marketCap":428034067720},{"date":"2025-10-03","current":19.765362,"twenty":16.872299,"median":23.703561,"eighty":27.89845,"marketCap":447902863414},{"date":"2025-10-10","current":20.307374,"twenty":16.872299,"median":23.676362,"eighty":27.89845,"marketCap":460185391661},{"date":"2025-10-17","current":18.419924,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":462690064088},{"date":"2025-10-24","current":18.422041,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":462743240559},{"date":"2025-10-31","current":18.132778,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":455477239033},{"date":"2025-11-07","current":17.933274,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":450465905220},{"date":"2025-11-14","current":18.727452,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":470414868665},{"date":"2025-11-21","current":19.477509,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":489255556363},{"date":"2025-11-28","current":19.846783,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":498531342505},{"date":"2025-12-05","current":19.420919,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":487834072252},{"date":"2025-12-12","current":20.143161,"twenty":16.872299,"median":23.669149,"eighty":27.89845,"marketCap":505976064371},{"date":"2025-12-19","current":19.980105,"twenty":16.872299,"median":23.666692,"eighty":27.89845,"marketCap":501880262697},{"date":"2025-12-26","current":19.92927,"twenty":16.872299,"median":23.663478,"eighty":27.89845,"marketCap":500603336293},{"date":"2026-01-02","current":19.84966,"twenty":16.872299,"median":23.657404,"eighty":27.89845,"marketCap":498603621358},{"date":"2026-01-09","current":19.734562,"twenty":16.872299,"median":23.638826,"eighty":27.89845,"marketCap":495712467236},{"date":"2026-01-16","current":21.060111,"twenty":16.872299,"median":23.629592,"eighty":27.89845,"marketCap":529008925546},{"date":"2026-01-23","current":19.639117,"twenty":16.872299,"median":23.613562,"eighty":27.89845,"marketCap":526406886835},{"date":"2026-01-30","current":20.430111,"twenty":16.872299,"median":23.593252,"eighty":27.867487,"marketCap":547608683733},{"date":"2026-02-06","current":21.37391,"twenty":16.872299,"median":23.571859,"eighty":27.346202,"marketCap":572906282304},{"date":"2026-02-13","current":21.981537,"twenty":16.872299,"median":23.541712,"eighty":26.962637,"marketCap":589193117194},{"date":"2026-02-20","current":22.199229,"twenty":16.872299,"median":23.524706,"eighty":26.835716,"marketCap":595028146287},{"date":"2026-02-27","current":21.889945,"twenty":16.872299,"median":23.516029,"eighty":26.616945,"marketCap":586738093947},{"date":"2026-03-06","current":21.544698,"twenty":16.872299,"median":23.487398,"eighty":26.496314,"marketCap":577484082033},{"date":"2026-03-13","current":21.761377,"twenty":16.872299,"median":23.466628,"eighty":26.378261,"marketCap":583291938469},{"date":"2026-03-20","current":21.350787,"twenty":16.872299,"median":23.428893,"eighty":26.272291,"marketCap":572286500834},{"date":"2026-03-23","current":21.150399,"twenty":16.872299,"median":23.410585,"eighty":26.25545,"marketCap":566915293356}],"updateTime":1774385386980},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JNJ\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618993740","title":"Johnson & Johnson submits EMA application for TECVAYLI monotherapy in relapsed or refractory multiple myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2618993740","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618993740?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:59","pubTimestamp":1773143986,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on March 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDLQF1TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0683600562.USD","LU1894683264.USD","LU2112291526.USD","LU0124676726.USD","LU0058720904.USD","LU0787776722.HKD","LU1066051811.HKD","LU1066051225.USD","LU0795875169.SGD","LU2430703095.HKD","LU1032466523.USD","BK4585","LU1674673691.USD","IE00BVYPNW00.USD","IE0002141913.USD","IE00B19Z3B42.SGD","LU1894683348.USD","LU0203345920.USD","IE00B19Z3581.USD","LU1267930813.SGD","LU2430703251.USD","LU2471134879.HKD","LU1162221912.USD","LU0203347892.USD","IE00BN8TJ469.HKD","BK4559","IE00B42XCP33.USD","LU2430703178.SGD","LU1221951129.SGD","IE00BGHQF631.EUR","IE00B3T34201.USD","SG9999002224.SGD","BK4533","IE00BDGV0183.EUR","LU0792757196.USD","IE00B4R5TH58.HKD","JNJ","LU1718418525.SGD","BK4581","LU1244550221.USD","LU2129689431.USD","SG9999002232.USD","IE0001KFT4U8.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","BK4534","BK4532","LU2750360997.AUD","LU1732800096.USD"],"gpt_icon":0},{"id":"2618937481","title":"Tecvayli®▼ (Teclistamab) Monotherapy Application Submitted to the Ema for Relapsed/Refractory Multiple Myeloma After at Least One Prior Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2618937481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618937481?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:56","pubTimestamp":1773143794,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY117:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2129689431.USD","LU1057294990.SGD","LU1674673691.USD","IE00BFXG1179.USD","LU1585245621.USD","LU1983299246.USD","LU2089984988.USD","LU1066051225.USD","LU1674673428.USD","LU2430703095.HKD","LU2602419157.SGD","IE0034235303.USD","SG9999002224.SGD","LU0234570918.USD","LU0787776722.HKD","BK4588","LU0689626769.HKD","BK4581","LU0345769631.USD","LU1929549753.HKD","LU1506573853.SGD","LU0889566641.SGD","IE00BSNM7G36.USD","LU1244550221.USD","LU0792757196.USD","LU1496350502.SGD","LU1935042991.SGD","LU2468319806.SGD","IE00B3PB1722.GBP","IE00BVYPNW00.USD","LU0124676726.USD","BK4550","JNJ","LU0683600562.USD","LU1894683348.USD","BK4007","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","LU0345770993.USD","LU1244550494.USD","LU1430594728.SGD","IE00BVYPNV92.GBP","LU2471134879.HKD","LU0432979614.USD","LU2750360641.GBP","LU1162221912.USD","LU1732800096.USD","BK4504","BK4559","LU2471134952.CNY"],"gpt_icon":0},{"id":"2618673253","title":"European Commission approves Johnson & Johnson’s AKEEGA for BRCA1/2-mutated mHSPC","url":"https://stock-news.laohu8.com/highlight/detail?id=2618673253","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618673253?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:06","pubTimestamp":1773075968,"startTime":"0","endTime":"0","summary":"The European Commission approved an expanded indication for AKEEGA  with prednisone or prednisolone plus androgen deprivation therapy for patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer. The decision was supported by Phase 3 AMPLITUDE data showing a 48% reduction in the risk of radiographic progression or death in BRCA1/2-mutated patients. In this subgroup, the overall survival analysis favored the regimen with a 20% lower risk of death.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on March 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDLch08XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2129689605.HKD","LU1732800096.USD","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","LU0203347892.USD","LU0345770993.USD","SG9999001440.SGD","LU1430594728.SGD","BK4007","LU0345770308.USD","LU1935042991.SGD","IE00BDGV0183.EUR","LU1057294990.SGD","LU0466842654.USD","LU0795875086.SGD","LU0122379950.USD","IE00BGHQF631.EUR","LU2468319806.SGD","IE00BZ1G4Q59.USD","LU0098860793.USD","LU0689626769.HKD","LU1061106388.HKD","LU1244550494.USD","LU0203345920.USD","LU1066051225.USD","LU2471134879.HKD","LU2471134796.USD","LU2750360641.GBP","JNJ","LU1074936037.SGD","LU2430703251.USD","LU1732799900.SGD","BK4588","LU1778281490.HKD","LU2133065610.SGD","LU1894683348.USD","BK4550","LU2089984988.USD","LU1244550577.SGD","LU1221951046.USD","IE00B1BXHZ80.USD","IE0034235303.USD","LU1718418525.SGD","LU0320765646.SGD","LU2505996509.AUD","IE00BVYPNV92.GBP","LU1506573853.SGD","LU1162221912.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2618673472","title":"J&J - European Commission Approves Akeega for Brca1/2-Mutated Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2618673472","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618673472?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:05","pubTimestamp":1773075917,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1929549753.HKD","LU2129689514.USD","BK4559","LU1894683264.USD","IE00B3T34201.USD","IE0002141913.USD","BK4534","LU0466842654.USD","LU1061106388.HKD","IE00B19Z3581.USD","LU1244550494.USD","IE00BSNM7G36.USD","LU0795875169.SGD","LU0795875086.SGD","LU1506573853.SGD","IE00B19Z3B42.SGD","IE0001KFT4U8.USD","LU0203347892.USD","LU0345770993.USD","LU0234570918.USD","LU0640476718.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BN8TJ469.HKD","JNJ","LU1778281490.HKD","LU1162221912.USD","LU1983299246.USD","LU2430703095.HKD","LU0345769631.USD","LU2430703178.SGD","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU0345769128.USD","IE0002270589.USD","LU2112291526.USD","LU0234572021.USD","IE00BDGV0183.EUR","LU1244550221.USD","IE00BZ1G4Q59.USD","LU0124676726.USD","LU0070217475.USD","LU1032955483.USD","IE00B2B36J28.USD","LU0792757196.USD","LU1732799900.SGD","LU2089984988.USD","LU0889566641.SGD","LU1066051225.USD","BK4550"],"gpt_icon":0},{"id":"2618649950","title":"Premier Foods appoints Matt Roberts as Chief Customer Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2618649950","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618649950?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:59","pubTimestamp":1773046787,"startTime":"0","endTime":"0","summary":"Premier Foods appointed Matt Roberts as Chief Customer Officer, effective 13 April. He replaces Richard Martin, who is retiring after nearly 20 years with the group. Roberts joins from Karo Healthcare, where he has been Chief Commercial Officer since 2021, and previously worked at Johnson & Johnson and Procter & Gamble.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Premier Foods plc published the original content used to generate this news brief on March 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL2V1srF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","BK4592","SG9999002224.SGD","LU2471134796.USD","SG9999015358.SGD","LU1935042991.SGD","LU1868837136.USD","JNJ","LU0912757837.SGD","PG","LU0683600562.USD","LU2242646821.SGD","LU0098860793.USD","LU1674673428.USD","BK4588","LU2505996509.AUD","LU2468319806.SGD","LU1066051225.USD","LU2592432038.USD","LU1057294990.SGD","LU2242652126.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","LU0795875086.SGD","BK4533","LU1430594728.SGD","LU0234572021.USD","BK4568","IE00B19Z3B42.SGD","BK4534","LU1894683264.USD","LU1267930813.SGD","LU0122379950.USD","BK5158","LU2471134952.CNY","LU1894683348.USD","SG9999014575.USD","SG9999015341.SGD","IE00BGHQF631.EUR","IE0002141913.USD","LU0237698245.USD","LU0787776722.HKD","LU0114720955.EUR","LU2430703251.USD","LU2552382132.HKD","PFD.UK","BK4007","LU0094547139.USD"],"gpt_icon":0},{"id":"2617655867","title":"Perrigo Co. PLC Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2617655867","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617655867?lang=en_us&edition=fundamental","pubTime":"2026-03-07 06:29","pubTimestamp":1772836140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 4.29% to $10.72 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 1.33% to 6,740.02 and Dow Jones Industrial Average  falling 0.95% to 47,501.55.This was the stock's second consecutive day of losses.Perrigo Co. PLC closed 63.14% below its 52-week high of $29.08, which the company reached on March 18th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.32% to $240.40, Procter & Gamble Co.  fell 0.23% to $153.63, and Abbott Laboratories  fell 1.33% to $109.56.Trading volume  eclipsed its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 6, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU1732800096.USD","LU0320765646.SGD","LU0234572021.USD","LU2750360997.AUD","LU1721429402.USD","LU0942090050.USD","LU0345770993.USD","IE0009355771.USD","LU0985320562.USD","LU1244550577.SGD","IE00BFMHRM44.USD","LU0882574055.USD","LU2750360641.GBP","BK4534","LU2471134523.USD","LU0124676726.USD","LU1032955483.USD","LU2129689605.HKD","ABT","PG","PRGO","LU0203345920.USD","IE00BWXC8680.SGD","LU0792757196.USD","LU0868494708.USD","LU1066051225.USD","LU1778281490.HKD","BK4585","IE00BFTCPJ56.SGD","IE0001KFT4U8.USD","IE00B3T34201.USD","LU0323591593.USD","LU2505996509.AUD","LU1059921491.USD","SGXZ23171101.USD","IE00B4R5TH58.HKD","LU2592432038.USD","LU0070217475.USD","LU0795875086.SGD","IE00BZ1G4Q59.USD","LU1718418525.SGD","JNJ","LU1868837300.USD","LU1162221912.USD","LU1868836757.USD","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU1894683348.USD","LU0787776722.HKD"],"gpt_icon":0},{"id":"2617327266","title":"Market Chatter: Johnson & Johnson Units to Pay $65 Million to Settle Tracleer Antitrust Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2617327266","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617327266?lang=en_us&edition=fundamental","pubTime":"2026-03-07 02:46","pubTimestamp":1772822786,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  units Actelion Pharmaceuticals and Janssen Research & Development have agreed to pay $65 million to settle a proposed antitrust class action alleging overcharging for the pulmonary artery hypertension drug Tracleer, Reuters reported Friday.The Government Employees Health Association and other entities that paid or reimbursed payments made by their members for Tracleer alleged in the lawsuit that the companies delayed competition for a generic version of the drug, according to the report.The preliminary settlement, which covers Tracleer purchases in 31 states, the District of Columbia and Puerto Rico from December 2015 to September 2024, was filed Wednesday in Maryland federal court and requires approval from a judge, Reuters said.Johnson & Johnson did not immediately respond to MT Newswires' request for comment.Price: 238.77, Change: -0.86, Percent Change: -0.36","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0098860793.USD","LU0203347892.USD","SG9999002232.USD","LU0114720955.EUR","LU0122379950.USD","LU1929549753.HKD","LU0058720904.USD","IE00B19Z3581.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU0985320562.USD","LU1894683264.USD","IE00B3T34201.USD","LU2505996681.GBP","IE0009355771.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999001440.SGD","LU0882574055.USD","LU1066051498.USD","JNJ","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","LU0234570918.USD","LU0345769631.USD","LU1506573853.SGD","LU1066051225.USD","LU0289739699.SGD","LU1023059063.AUD","LU1162221912.USD","IE00BSNM7G36.USD","LU2430703251.USD","LU1585245621.USD","LU0889566641.SGD","IE000M9KFDE8.USD","LU1674673691.USD","LU2129689514.USD","LU0345770993.USD","IE00BDGV0183.EUR","IE0002270589.USD","LU1221951046.USD","LU1430594728.SGD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU2430703095.HKD","IE00B4R5TH58.HKD","LU1674673428.USD","LU2129689605.HKD","LU0792757196.USD"],"gpt_icon":0},{"id":"2617684565","title":"Procept BioRobotics names Daniel Puckett to board and audit committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2617684565","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617684565?lang=en_us&edition=fundamental","pubTime":"2026-03-06 19:02","pubTimestamp":1772794964,"startTime":"0","endTime":"0","summary":"Procept BioRobotics increased its board size to nine members and appointed Daniel Puckett as a new director. Puckett was also appointed to the board’s Audit Committee, effective immediately. He previously served as CFO of Shockwave Medical from April 2016 until his retirement in February 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL8k33nK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","IE00BKVL7J92.USD","IE00BLSP4239.USD","LU1059921491.USD","LU1430594728.SGD","LU2133065610.SGD","LU1894683348.USD","LU2324357040.USD","LU2129689431.USD","LU1061106388.HKD","LU0124676726.USD","IE00BJJMRZ35.SGD","LU1778281490.HKD","LU1506573853.SGD","BK4532","LU0882574055.USD","LU2750360997.AUD","BK4533","LU0345770308.USD","JNJ","LU0689626769.HKD","LU1935042991.SGD","BK4504","LU1674673691.USD","LU0345770993.USD","LU2468319806.SGD","LU2089984988.USD","LU2471134796.USD","BK4007","LU0320765646.SGD","LU2430703251.USD","LU0795875169.SGD","LU1244550221.USD","LU0234572021.USD","LU0912757837.SGD","LU1674673428.USD","IE0034235303.USD","PRCT","LU0070217475.USD","LU1066051811.HKD","IE00BFXG1179.USD","BK4082","LU1244550577.SGD","SG9999002224.SGD","LU0289739699.SGD","LU2112291526.USD","BK4568","LU1221951046.USD","LU1162221912.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2617576378","title":"Johnson & Johnson Is Maintained at Neutral by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617576378?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:09","pubTimestamp":1772744940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JNJ/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2026 16:09 ET (21:09 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2617575053","title":"Contineum Q4 FY2025 net loss totals USD 15.2 million as G&A expenses rise 8.0% to USD 4.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617575053","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617575053?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:06","pubTimestamp":1772744779,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics reported Q4 2025 results, posting a net loss of USD 15.2 million and R&D expenses of USD 12.8 million , while G&A expenses rose to USD 4.4 million . Cash, cash equivalents and marketable securities totaled USD 262.9 million at December 31, 2025, and the company said its cash resources are sufficient to fund planned operations through mid-2029; during Q4 it completed an upsized public offering generating net proceeds of USD 93.0 million from the issuance of approximately 8.1 million Class A shares at USD 12.25. On the business side, Contineum said it has initiated patient dosing in PROPEL-IPF, a global Phase 2 trial of once-daily oral PIPE-791 in idiopathic pulmonary fibrosis . The company also reiterated it expects topline data in Q2 2026 from an exploratory Phase 1b PIPE-791 trial in chronic osteoarthritis pain or chronic lower back pain, and noted Johnson & Johnson began recruiting in December 2024 for the Phase 2 Moonlight-1 trial of PIPE-307/JNJ-89495120 in m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL3glqSn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNV92.GBP","JNJ","BK4504","LU2133065610.SGD","LU1894683264.USD","LU2471134879.HKD","IE00BLSP4239.USD","LU0466842654.USD","IE00BJJMRZ35.SGD","LU1066051225.USD","LU0792757196.USD","LU1066053197.SGD","LU0795875169.SGD","LU0234572021.USD","LU1244550494.USD","BK4568","IE00B2B36J28.USD","LU0058720904.USD","LU0912757837.SGD","BK4581","BK4550","LU2505996509.AUD","SG9999002232.USD","IE00B3PB1722.GBP","LU0345770308.USD","BK4585","LU1674673428.USD","CTNM","LU1718418525.SGD","LU1935042991.SGD","IE00BGHQF631.EUR","LU0070217475.USD","IE00B3T34201.USD","LU1894683348.USD","LU2112291526.USD","IE00B42XCP33.USD","LU2347655156.SGD","LU0203347892.USD","LU0882574055.USD","LU1059921491.USD","LU1929549753.HKD","LU2592432038.USD","LU1983299246.USD","LU0114720955.EUR","LU0289739699.SGD","IE00BSNM7G36.USD","IE0001KFT4U8.USD","LU2471134796.USD","LU1674673691.USD","IE0034235303.USD"],"gpt_icon":0},{"id":"2617575774","title":"Press Release: Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2617575774","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617575774?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:05","pubTimestamp":1772744700,"startTime":"0","endTime":"0","summary":"- Patient dosing initiated in PROPEL-IPF, a global Phase 2 trial evaluating PIPE-791 for the treatment of patients with idiopathic pulmonary fibrosis . - Topline data from the exploratory PIPE-791 Phase 1b trial in patients with chronic pain is expected in the second quarter of 2026. Contineum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology  indications, today reported its fourth-quarter 2025 financial results and affirmed its key clinical development milestones.\"We're off to a strong start in 2026, having recently dosed the first patient in our global Phase 2 idiopathic pulmonary fibrosis  trial, \" said Carmine Stengone, CEO, Contineum Therapeutics. \"IPF is a devastating disease that profoundly impacts patients and their families. We're urgently advancing PIPE-791 with the goal of developing a transformative therapy that we believe could address the limitations of curren","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0098860793.USD","LU2129689514.USD","IE00BVYPNV92.GBP","LU0985320562.USD","LU0345770993.USD","LU0689626769.HKD","LU2602419157.SGD","LU1066053197.SGD","LU2471134879.HKD","JNJ","LU0795875086.SGD","IE00B4R5TH58.HKD","LU2133065610.SGD","LU2468319806.SGD","BK4559","BK4550","LU0345769631.USD","LU2505996681.GBP","LU0432979614.USD","LU0640476718.USD","LU2129689431.USD","IE00BSNM7G36.USD","LU2430703095.HKD","LU0345769128.USD","LU0320765646.SGD","BK4588","LU1894683264.USD","LU2129689605.HKD","LU1196500208.SGD","IE00BJT1NW94.SGD","IE0002270589.USD","IE00B3PB1722.GBP","LU2592432038.USD","IE00B19Z3B42.SGD","IE0001KFT4U8.USD","LU0124676726.USD","LU1718418525.SGD","IE00B2B36J28.USD","IE00BN8TJ469.HKD","LU1267930813.SGD","LU1023059063.AUD","IE00BKVL7J92.USD","LU1162221912.USD","LU2471134796.USD","LU0795875169.SGD","CTNM","BK4568","IE00BFTCPJ56.SGD","LU1935042991.SGD"],"gpt_icon":0},{"id":"2617630575","title":"Johnson & Johnson Announces U.S. FDA Approval of Tecvayli® Plus Darzalex Faspro® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630575?lang=en_us&edition=fundamental","pubTime":"2026-03-06 04:55","pubTimestamp":1772744127,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nTUA2GK6CW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JNJ","LU2471134796.USD","BK4568","LU2129689431.USD","LU0070217475.USD","LU1430594728.SGD","IE0009355771.USD","LU2089984988.USD","LU2592432038.USD","LU1983299246.USD","LU2750360997.AUD","LU0792757196.USD","IE00B3T34201.USD","LU1057294990.SGD","LU2471134879.HKD","BK4559","IE00BDGV0183.EUR","BK4550","LU1914381329.SGD","LU1778281490.HKD","LU0289739699.SGD","IE00B42XCP33.USD","LU1162221912.USD","LU1074936037.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0345769631.USD","LU1061106388.HKD","LU1221951046.USD","LU1929549753.HKD","IE00BN8TJ469.HKD","BK4533","LU2750360641.GBP","LU0203345920.USD","LU1496350502.SGD","SG9999001440.SGD","IE00BFXG1179.USD","BK4532","LU1674673428.USD","LU1718418525.SGD","LU1585245621.USD","LU1221951129.SGD","LU1032955483.USD","LU0640476718.USD","LU1732800096.USD","LU0234572021.USD","LU2471134952.CNY","IE00B19Z3B42.SGD","LU0432979614.USD","LU1280957306.USD"],"gpt_icon":0},{"id":"2617737365","title":"FDA approves Johnson & Johnson’s Tecvayli plus Darzalex Faspro for relapsed or refractory multiple myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2617737365","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617737365?lang=en_us&edition=fundamental","pubTime":"2026-03-06 04:32","pubTimestamp":1772742764,"startTime":"0","endTime":"0","summary":"Johnson & Johnson said the U.S. Food and Drug Administration approved TECVAYLI  in combination with DARZALEX FASPRO  to treat adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent. The company said the approval was based on Phase 3 MajesTEC-3 data and noted the application received Breakthrough Therapy Designation and Real-Time Oncology Review and was included in the FDA Commissioner’s National Priority Voucher Pilot Program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on March 05, 2026, and is solely responsible for the information contai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLc1RflW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU2112291526.USD","LU0124676726.USD","BK4007","LU0058720904.USD","LU1066051225.USD","LU2750360641.GBP","LU1221951046.USD","BK4585","LU0070217475.USD","LU0234570918.USD","IE00BSNM7G36.USD","LU1894683348.USD","LU1061106388.HKD","LU1430594728.SGD","LU1244550494.USD","LU0689626769.HKD","LU1983299246.USD","BK4588","IE00BKVL7J92.USD","BK4568","BK4559","LU2471134952.CNY","LU2505996509.AUD","LU1059921491.USD","LU1221951129.SGD","IE00B3T34201.USD","LU1244550577.SGD","LU1023059063.AUD","BK4533","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0466842654.USD","LU0345769631.USD","LU1261432733.SGD","IE00BDGV0183.EUR","LU2505996681.GBP","JNJ","IE000M9KFDE8.USD","LU1718418525.SGD","BK4581","LU1244550221.USD","SG9999002232.USD","LU1778281490.HKD","IE00B1BXHZ80.USD","IE00BLSP4452.SGD","BK4534","LU2750360997.AUD","LU0320765646.SGD","LU0640476718.USD"],"gpt_icon":0},{"id":"2617857353","title":"Johnson & Johnson's Janssen Biotech Unit Secures US FDA Approval for Multiple Myeloma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2617857353","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617857353?lang=en_us&edition=fundamental","pubTime":"2026-03-06 03:58","pubTimestamp":1772740690,"startTime":"0","endTime":"0","summary":"Johnson & Johnson's  Janssen Biotech unit received the US Food and Drug Administration's approval for the Tec-Dara drug combination to treat adults with multiple myeloma who have received at least one prior therapy, the health regulator said Thursday.A late-stage clinical trial showed the combination reduced the risk of the condition worsening or fatality by 83% compared with the usual treatments, the FDA said.The FDA added that this supporting clinical data also transitioned the standalone Tecvayli medication from an accelerated clearance to a conventional approval.Price: 237.28, Change: -8.03, Percent Change: -3.27","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0640476718.USD","IE00BFTCPJ56.SGD","LU1732799900.SGD","IE00B19Z3581.USD","LU0795875169.SGD","BK4588","LU1221951046.USD","LU2089984988.USD","LU1935042991.SGD","LABU","LU1718418525.SGD","BK4550","IE00BN8TJ469.HKD","JNJ","BK4007","BK4592","LU0345769128.USD","IE00BKVL7J92.USD","BK4504","LU0114720955.EUR","LU1914381329.SGD","LU2129689431.USD","IE00B4R5TH58.HKD","IE000M9KFDE8.USD","LU0289739699.SGD","IE0034235303.USD","LU2112291526.USD","IE00B42XCP33.USD","LU1061106388.HKD","LU1674673691.USD","LU0070217475.USD","LU1023059063.AUD","IE0002270589.USD","IE00B1BXHZ80.USD","LU1496350502.SGD","LU1280957306.USD","LU0122379950.USD","LU2471134952.CNY","LU1032955483.USD","IE00BJT1NW94.SGD","LU0234572021.USD","LU2505996509.AUD","LU2471134523.USD","SG9999002232.USD","IE00B2B36J28.USD","LU0320765646.SGD","LU1196500208.SGD","LU2347655156.SGD","BK4581","LU1244550494.USD"],"gpt_icon":0},{"id":"2617457894","title":"US FDA approves JNJ's blood cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2617457894","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617457894?lang=en_us&edition=fundamental","pubTime":"2026-03-06 03:18","pubTimestamp":1772738339,"startTime":"0","endTime":"0","summary":"US FDA approvesJNJ's blood cancer drugMarch 5  - The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's JNJ.N treatment for a type of blood cancer, making it the third drug cleared under the agency's new speedy review program.The health regulator approved the use of Tecvayli in combination with Darzalex in patients with myeloma who have received at least one prior line of therapy.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL6N3ZT1DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","BK4592","SG9999001440.SGD","LU2471134796.USD","LU0203345920.USD","LU0098860793.USD","LU0683600562.USD","LU0689626769.HKD","LU1066053197.SGD","BK4007","LU0640476718.USD","LU1032466523.USD","IE00B2B36J28.USD","IE00BVYPNV92.GBP","LU0912757837.SGD","LU1023059063.AUD","LU1267930813.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU1894683264.USD","LU1196500208.SGD","LU0795875086.SGD","LU1066051225.USD","IE00BVYPNW00.USD","LU1074936037.SGD","JNJ","LU1066051498.USD","LU1244550221.USD","IE0002270589.USD","LU2430703251.USD","LU1061106388.HKD","LU1066051811.HKD","LU2602419157.SGD","LU0889566641.SGD","LU1674673691.USD","IE00B3T34201.USD","LU0985320562.USD","LU1778281490.HKD","IE0002141913.USD","IE00B1BXHZ80.USD","IE00B42XCP33.USD","BK4568","LU0432979614.USD","LU0122379950.USD","LU0792757196.USD","LU0345770993.USD","IE00BN8TJ469.HKD","IE00BGHQF631.EUR","BK4581","LU0882574055.USD"],"gpt_icon":0},{"id":"2617520403","title":"BRIEF-FDA Grants Third Approval Under National Priority Voucher Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520403","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617520403?lang=en_us&edition=fundamental","pubTime":"2026-03-06 02:43","pubTimestamp":1772736188,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Grants Third Approval Under National Priority Voucher ProgramMarch 5 (Reuters) - U.S. FDA: U.S. FDA - APPROVES TEC-DARA FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMAFDA GRANTS THIRD APPROVAL UNDER NATIONAL PRIORITY VOUCHER PROGRAM ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT1HA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","IE00BZ1G4Q59.USD","IE000M9KFDE8.USD","LU2471134523.USD","LU1935042991.SGD","IE00BN8TJ469.HKD","LU1244550494.USD","LU2430703178.SGD","LU1718418525.SGD","LU1059921491.USD","LU0124676726.USD","LU0640476718.USD","LU2112291526.USD","LU0889566641.SGD","LU0058720904.USD","SG9999002232.USD","IE00BLSP4239.USD","LU0795875086.SGD","LU1261432733.SGD","BK4533","BK4007","BK4550","LU1066051498.USD","LU2471134879.HKD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU2129689605.HKD","LU2347655156.SGD","IE0001KFT4U8.USD","LU1894683264.USD","LU2505996681.GBP","LU1674673428.USD","BK4534","LU0114720955.EUR","LU2430703251.USD","LU2471134796.USD","IE00BVYPNW00.USD","IE0002270589.USD","LU0792757196.USD","LU1267930813.SGD","LU1674673691.USD","LU0098860793.USD","LU1032955483.USD","BK4588","LU2750360641.GBP","BK4592","IE00BVYPNV92.GBP","IE0002141913.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2617520194","title":"US FDA - Approves Tec-Dara for Relapsed or Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617520194?lang=en_us&edition=fundamental","pubTime":"2026-03-06 02:38","pubTimestamp":1772735914,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT1HA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1244550577.SGD","LU1929549753.HKD","LU2505996509.AUD","JNJ","LU1261432733.SGD","IE0002141913.USD","LU0289739699.SGD","LU0787776722.HKD","IE00BVYPNV92.GBP","IE00B3T34201.USD","IE00B4R5TH58.HKD","LU0792757196.USD","LU0683600562.USD","IE0002270589.USD","LU1032466523.USD","LU1244550494.USD","LU1430594728.SGD","BK4550","IE00BFXG1179.USD","IE00BN8TJ469.HKD","LU2471134796.USD","LU2133065610.SGD","LU0345769128.USD","LU1032955483.USD","LU2089984988.USD","LU2471134952.CNY","LU0889566641.SGD","LU0203345920.USD","BK4588","LU1221951129.SGD","LU2750360997.AUD","LU1023059063.AUD","SG9999002232.USD","LU1732799900.SGD","LU0912757837.SGD","LU1674673428.USD","LU0320765646.SGD","LU2468319806.SGD","LU2430703178.SGD","BK4007","IE00BLSP4239.USD","LU0070217475.USD","LU1196500208.SGD","LU0114720955.EUR","IE00BJJMRZ35.SGD","IE00BGHQF631.EUR","IE00B19Z3581.USD","LU2430703095.HKD","LU1983299246.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2617524825","title":"United Therapeutics Seen as Top Pick on Multiple Near-Term Catalysts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2617524825","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617524825?lang=en_us&edition=fundamental","pubTime":"2026-03-06 00:34","pubTimestamp":1772728489,"startTime":"0","endTime":"0","summary":"United Therapeutics  remains a \"top pick\" due to several near- to medium-term catalysts that could drive upside, UBS Securities analysts said in a report Thursday.The firm said upcoming clinical trial data for \"Tyvaso\" in idiopathic pulmonary fibrosis, expected in late March or early April, could lift the stock, particularly if followed by a fast approval and \"accelerated launch,\" and a potential update on the company's intellectual property dispute with Liquidia  is another possible catalyst.The company's \"soft-mist treprostinil inhaler\" announced during Q4 earnings, surprised investors, with its management indicating it could seek regulatory approval based on \"stability and bioequivalence\" data in healthy volunteers and potentially launch the product in 2027, the report said.Analysts also highlighted strong Phase 3 data for \"Ralinepag\" in pulmonary arterial hypertension, could allow the drug to capture market share from Johnson & Johnson's  Uptravi.UBS has a buy rating on United Ther","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1244550577.SGD","LU2750360641.GBP","UTHR","LU1929549753.HKD","LU2505996509.AUD","IE0034235303.USD","JNJ","IE0002141913.USD","LU1894683264.USD","LU2471134879.HKD","LU1066051811.HKD","LU0640476718.USD","IE00BVYPNV92.GBP","LU0345769631.USD","LU0432979614.USD","LU0058720904.USD","LU1162221912.USD","LU0792757196.USD","IE00BFTCPJ56.SGD","LU1032466523.USD","LU1066051498.USD","LU2602419157.SGD","BK4550","IE00BN8TJ469.HKD","LU1718418525.SGD","LU1244550221.USD","IE00BDGV0183.EUR","LU0203347892.USD","LU0795875086.SGD","LU1894683348.USD","LU2471134796.USD","LU0098860793.USD","LU2133065610.SGD","LU2471134952.CNY","IE00B3PB1722.GBP","LU2089984988.USD","LU2129689514.USD","BK4588","IE00BZ1G4Q59.USD","LU1023059063.AUD","LQDA","LU1674673428.USD","LU0320765646.SGD","LU2468319806.SGD","BK4534","LU0070217475.USD","LU0114720955.EUR","BK4559","IE00B19Z3581.USD","LU1983299246.USD"],"gpt_icon":0},{"id":"2617250725","title":"Dow's 400-Point Fall Led By Losses In Shares Of Walmart, Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2617250725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617250725?lang=en_us&edition=fundamental","pubTime":"2026-03-05 22:45","pubTimestamp":1772721900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Walmart and Merck are posting losses Thursday morning, sending the Dow Jones Industrial Average into negative territory.Shares of Walmart  and Merck  are contributing to the blue-chip gauge's intraday decline, as the Dow  was most recently trading 399 points  lower.Walmart's shares are down $3.43  while those of Merck are off $2.92, or 2.4%, combining for an approximately 39-point drag on the Dow.Other components contributing significantly to the decline include Johnson & Johnson , Caterpillar , and Procter & Gamble .A $1 move in any of the Dow's 30 components results in a 6.16-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1935042991.SGD","SG9999015341.SGD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU1069347547.HKD","LU1201861249.SGD","IE0002270589.USD","MRK","LU0912757837.SGD","LU1894683348.USD","LU2357305700.SGD","LU2471134879.HKD","LU1074936037.SGD","LU2237438978.USD","LU1974910355.USD","SG9999014567.USD","IE0034235188.USD","IE00BSNM7G36.USD","LU1366192091.USD","IE00B19Z3B42.SGD","SG9999015358.SGD","LU0048573561.USD","SCHD","IE00B4R5TH58.HKD","LU0417517546.SGD","LU0868494617.USD","BK4558","LU1934455863.HKD","LU1061106388.HKD","LU1868836757.USD","LU0353189763.USD","LU0689626769.HKD","LU1548497426.USD","LU0203347892.USD","LU1116320901.HKD","LU0122379950.USD","LU2361044949.HKD","IE0009355771.USD","LU0265550359.USD","LU1066051498.USD","LU1718418525.SGD","IE00BLSP4239.USD","LU0477156953.USD","LU0868494708.USD","LU0256863811.USD","IE0001KFT4U8.USD","LU1814569148.SGD","DIA","LU2242652126.USD","LU2361045086.USD","MYMmain","LU0965509101.SGD","LU1244550494.USD","LU2471134523.USD","IE00B3T34201.USD","LU2471134796.USD","LU0238689110.USD","LU1066051225.USD","LU0234570918.USD","IE000M9KFDE8.USD","DOG","IE00BD6J9T35.USD","LU0661504455.SGD","LU0882574055.USD","LU0738911758.USD","GB00BDT5M118.USD","LU1291159041.SGD","LU1674673691.USD","IE00BJT1NW94.SGD","LU2361044865.SGD","BK4533","LU2746668461.USD","LU0251131958.USD",".DJI","LU0266013472.USD","BK4559","LU1057294990.SGD","LU2430703251.USD","DXD","IE00B3PB1722.GBP","BK4532","LU0130517989.USD","IE00BKVL7J92.USD","LU1674673428.USD","WMTI","IE00BVYPNV92.GBP","LU0256863902.USD","LU2552382058.USD","LU1988902786.USD","LU2324357040.USD","LU1196500208.SGD","LU0310799852.SGD","LU0124676726.USD","LU2125154935.USD","IE00BBT3K403.USD","BK4597","LU0203345920.USD","LU1066051811.HKD","BK4585","LU1585245621.USD","LU1244550577.SGD","SG9999002224.SGD","LU2505996681.GBP","LU2089984988.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU1941712264.USD","LU0345770308.USD","LU1868837300.USD","LU1914381329.SGD","BK4504","LU0211331839.USD","LU0211327993.USD","DDM","LU2592432038.USD","BK4155","LU1941712348.USD","LU1868836591.USD","LU0553294199.USD","IE00B1XK9C88.USD","IE00BFXG1179.USD","LU1934455277.USD","LU0466842654.USD","LU1244550221.USD","LU2023250843.SGD","BK4588","LU0175139822.USD","LU2097829019.USD","LU0149725797.USD","LU0345769631.USD","LU1989772840.SGD","LU0792757196.USD","LU0058720904.USD","LU2746668974.SGD","SDOW","LU0070302665.USD","LU1506573853.SGD","LU2106854487.HKD","LU0098860793.USD","LU2430703095.HKD","SG9999014575.USD","LU0323591593.USD","JNJ","LU0942090050.USD","IE00B2B36J28.USD","LU2543165471.USD","LU1496350502.SGD","LU0985320562.USD","SG9999013999.USD","LU2023250504.SGD","LU2602419157.SGD","LU1280957306.USD","IE00B19Z3581.USD","BK4516","LU0096364046.USD","LU1059921491.USD","SG9999014542.SGD","IE00BFTCPJ56.SGD","LU2129689605.HKD","LU1066053197.SGD","LU1894683264.USD","LU1003077747.HKD","LU1023059063.AUD","LU1221951046.USD","SG9999001176.USD","LU1261432733.SGD","LU0114720955.EUR","SGXZ57979304.SGD","LU2125154778.USD","LU1778281490.HKD","LU1032466523.USD","IE0002141913.USD","LU1732799900.SGD","LU0006306889.USD","LU0096362180.USD","IE00BN8TJ469.HKD","LU0061474960.USD","LU0208291251.USD","LU2112291526.USD","LU0640476718.USD","LU0980610538.SGD","LU2129689514.USD","LU0106261372.USD","LU0965509283.SGD","LU0320765489.SGD","BK4018","BK4592","LU0070217475.USD","LU0742534661.SGD","LU1267930490.SGD","LU1929549753.HKD","LU1983299246.USD","SG9999002232.USD","LU0251142724.SGD","LU1720051017.SGD","IE0034235303.USD","LU0683600562.USD","BK4534","LU1868836914.USD","LU2430703178.SGD","LU2468319806.SGD","LU0234572021.USD","LU2505996509.AUD","SG9999014559.SGD","LU0289739699.SGD","LU1032955483.USD","LU1035773651.USD","LU1868837136.USD","IE00BGHQF631.EUR","LU0094547139.USD","LU1267930813.SGD","LU2471134952.CNY","LU2750360641.GBP","LU1064131342.USD","BK4149","BK4567","IE00BDGV0183.EUR","LU0061475181.USD","LU1917777945.USD","WMT","LU0965509010.AUD","LU1430594728.SGD","LU2461242641.AUD","LU0949170772.SGD","LU0314104364.USD","IE00BVYPNW00.USD","LU2347655156.SGD","LU0965508806.USD","DJX","IE00BWXC8680.SGD","LU0795875086.SGD","BK4007","IE00B42XCP33.USD","LU0130102774.USD","BK4581","LU0545039389.USD","LU1732800096.USD","LU2552382132.HKD","LU2129689431.USD","LU2750360997.AUD","LU0889566641.SGD","LU2264538146.SGD","LU2087625088.SGD","BK4596","LU1989772923.USD","LU0787776722.HKD","LU0320765646.SGD","LU0795875169.SGD","LU0861579265.USD","LU1934455194.USD","LU2552382215.SGD","LU1162221912.USD","LU1571399168.USD","BK4520","LU1037948541.HKD","LU2360032135.SGD","IE00B7SZLL34.SGD","IE00B1BXHZ80.USD","LU0648001328.SGD","LU1116320737.USD","LU0345769128.USD","LU1720051108.HKD","LU1037948897.HKD","LU2133065610.SGD","LU0237698245.USD","LU0353189680.USD","LU1221951129.SGD","LU1093756325.SGD","SG9999001440.SGD","UDOW","LU1699723380.USD","LU0211328371.USD","SG9999001176.SGD","LU0345770993.USD","IE00BLSP4452.SGD","LU1815333072.USD","LU0432979614.USD","LU0289960550.SGD","LU0957791311.USD","LU0265550946.USD","BK4568","BK4550"],"gpt_icon":0},{"id":"2617546113","title":"Johnson & Johnson price target raised to $250 from $225 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2617546113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617546113?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:21","pubTimestamp":1772709670,"startTime":"0","endTime":"0","summary":"JPMorgan raised the firm’s price target on Johnson & Johnson to $250 from $225 and keeps a Neutral rating on the shares. The firm cites its increas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-price-target-raised-to-250-from-225-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-price-target-raised-to-250-from-225-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JNJ"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":199,"code":"91000000","status":"200"}]}}